Abstract:An enzymatic method has been successfully established enabling the generation of partially base-modified RNA (previously named RZA) constructs, in which all G residues were replaced by isomorphic fluorescent thienoguanosine ( th G) analogs, as well as fully modified RZA featuring th G, 5-bromocytosine, 7-deazaadenine and 5-chlorouracil. The transcriptional efficiency of emissive fully modified RZA was found to benefit from the use of various T7 RNA polymerase variants. Moreover, d th G could be incorporated into PCR products by Taq DNA polymerase together with the other three base-modified nucleotides. Notably, the obtained RNA products containing th G as well as th G together with 5-bromocytosine could function as effectively as natural sgRNAs in an in vitro CRISPR-Cas9 cleavage assay. N 1 -Methylpseudouridine was also demonstrated to be a faithful non-canonical substitute of uridine to direct Cas9 nuclease cleavage when incorporated in sgRNA. The Cas9 inactivation by 7-deazapurines indicated the importance of the 7-nitrogen atom of purines in both sgRNA and PAM site for achieving efficient Cas9 cleavage. Additional aspects of this study are discussed in relation to the significance of sgRNA–protein and PAM–-protein interactions that were not highlighted by the Cas9–sgRNA–DNA complex crystal structure. These findings could expand the impact and therapeutic value of CRISPR-Cas9 and other RNA-based technologies. Nucleobase modifications enzymatically incorporated into the CRISPR-Cas9 system revealed the tolerance of Cas9 to m1Ψ- and fluorescent th G-modified sgRNA and requirements for PAM recognition. With the advent of CRISPR-Cas9 gene editing, we now have to hand a simple two-component system amendable to silencing and knock-in editing effectively any gene. Yet we must not forget that the implications of immunotoxicity along with the poor stability and specificity of canonical nucleic acids hold enormous challenges for in vivo applications, especially in gene therapy. Our study endorses the feasibility of the enzymatic approach to incorporate nucleobase modifications into the CRISPR-Cas9 system unveiling the tolerance of Cas9 to N 1 -methylpseudouridine (m1Ψ)- and emissive thienoguanosine ( th G)-modified sgRNA as well as thus far uncharted structural requirements for ensuring proper PAM recognition.

Construction of non-canonical PAM-targeting adenosine base editors by restriction enzyme-free DNA cloning using CRISPR-Cas9

A Cas9 with PAM recognition for adenine dinucleotides

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences

Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing

Engineering Nme2Cas9 Adenine Base Editors with Improved Activity and Targeting Scope

Engineering a Precise Adenine Base Editor with Minimal Bystander Editing.

Engineering precise adenine base editor with infinitesimal rates of bystander mutations and off-target editing

Docking Sites Inside Cas9 For Adenine Base Editing Diversification And Rna Off-Target Elimination

Phage-assisted evolution of compact Cas9 variants targeting a simple NNG PAM

CRISPR-Cas9 recognition of enzymatically synthesized base-modified nucleic acids

Precision genome editing using combinatorial viral vector delivery of CRISPR-Cas9 nucleases and donor DNA constructs

Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope

Engineered domain-inlaid Nme2Cas9 adenine base editors with increased on-target DNA editing and targeting scope

Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Rational Design of Enhanced Nme2Cas9 and Nme2 Cas9 Nucleases and Base Editors

Expanding targeting scope, editing window, and base transition capability of base editing in Corynebacterium glutamicum.

Highly Efficient Base Editing in Staphylococcus Aureus Using an Engineered CRISPR RNA-guided Cytidine Deaminase.

Programming PAM antennae for efficient CRISPR-Cas9 DNA editing

Expanding the Genome-Targeting Scope and the Site Selectivity of High-Precision Base Editors

The Construction of a PAM-less Base Editing Toolbox in Bacillus Subtilis and Its Application in Metabolic Engineering